MEI Pharma, Inc. Annual Revenues in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
MEI Pharma, Inc. quarterly/annual Revenues history and growth rate from 2017 to 2024.
  • MEI Pharma, Inc. Revenues for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • MEI Pharma, Inc. Revenues for the twelve months ending June 30, 2024 was $65.3M, a 33.8% increase year-over-year.
  • MEI Pharma, Inc. annual Revenues for 2024 was $65.3M, a 33.8% increase from 2023.
  • MEI Pharma, Inc. annual Revenues for 2023 was $48.8M, a 20% increase from 2022.
  • MEI Pharma, Inc. annual Revenues for 2022 was $40.7M, a 17% increase from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $65.3M +$16.5M +33.8% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-19
2023 $48.8M +$8.12M +20% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-19
2022 $40.7M +$5.9M +17% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-26
2021 $34.8M +$7.04M +25.4% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-08
2020 $27.8M +$22.8M +465% Jul 1, 2019 Jun 30, 2020 10-K 2022-09-08
2019 $4.92M +$3.29M +203% Jul 1, 2018 Jun 30, 2019 10-K/A 2022-05-23
2018 $1.62M -$21.6M -93% Jul 1, 2017 Jun 30, 2018 10-K 2020-09-09
2017 $23.2M Jul 1, 2016 Jun 30, 2017 10-K 2019-08-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.